Ray Dalio's CLX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 7,539 shares of The Clorox Company (CLX) worth $760,157, representing 0.00% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in CLX, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2019, adding 91,524 shares. Largest reduction occurred in Q4 2019, reducing 180,535 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's The Clorox Company (CLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Clorox Company (CLX) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -11,894 | Reduce 61.21% | 7,539 | $100.83 |
| Q3 2025 | +12,452 | Add 178.37% | 19,433 | $123.30 |
| Q2 2025 | -2,186 | Reduce 23.85% | 6,981 | $120.07 |
| Q1 2025 | -13,154 | Reduce 58.93% | 9,167 | $147.25 |
| Q4 2024 | -11,063 | Reduce 33.14% | 22,321 | $162.41 |
| Q3 2024 | -147,683 | Reduce 81.56% | 33,384 | $162.91 |
| Q2 2024 | -17,039 | Reduce 8.60% | 181,067 | $136.47 |
| Q1 2024 | +27,927 | Add 16.41% | 198,106 | $153.11 |
| Q4 2023 | +4,173 | Add 2.51% | 170,179 | $142.59 |
| Q3 2023 | -40,364 | Reduce 19.56% | 166,006 | $131.06 |
| Q2 2023 | -20,586 | Reduce 9.07% | 206,370 | $159.04 |
| Q1 2023 | -53,907 | Reduce 19.19% | 226,956 | $158.24 |
| Q4 2022 | +48,395 | Add 20.82% | 280,863 | $140.33 |
| Q3 2022 | -62,694 | Reduce 21.24% | 232,468 | $128.39 |
| Q2 2022 | -16,876 | Reduce 5.41% | 295,162 | $140.98 |
| Q1 2022 | +61,386 | Add 24.49% | 312,038 | $139.03 |
| Q4 2021 | +15,582 | Add 6.63% | 250,652 | $174.36 |
| Q3 2021 | +7,063 | Add 3.10% | 235,070 | $165.61 |
| Q2 2021 | +80,177 | Add 54.24% | 228,007 | $179.91 |
| Q1 2021 | +17,066 | Add 13.05% | 147,830 | $192.88 |
| Q4 2020 | +67,723 | Add 107.43% | 130,764 | $201.92 |
| Q3 2020 | +58,457 | Add 1275.24% | 63,041 | $210.16 |
| Q2 2020 | -2,277 | Reduce 33.19% | 4,584 | $219.46 |
| Q1 2020 | +6,861 | New Buy | 6,861 | $173.30 |
| Q4 2019 | -180,535 | Sold Out | 0 | $0.00 |
| Q3 2019 | +36,812 | Add 25.61% | 180,535 | $151.87 |
| Q2 2019 | +91,524 | Add 175.34% | 143,723 | $153.11 |
| Q1 2019 | +52,199 | New Buy | 52,199 | $160.46 |
| Q1 2017 | -23,360 | Sold Out | 0 | $0.00 |
| Q4 2016 | -37,620 | Reduce 61.69% | 23,360 | $120.03 |
| Q3 2016 | +60,980 | New Buy | 60,980 | $125.17 |
| Q2 2016 | -15,817 | Sold Out | 0 | $0.00 |
| Q1 2016 | +12,948 | Add 451.31% | 15,817 | $126.07 |
| Q4 2015 | +2,869 | New Buy | 2,869 | $126.87 |
| Q3 2015 | -5,946 | Sold Out | 0 | $0.00 |
| Q2 2015 | -30,796 | Reduce 83.82% | 5,946 | $104.10 |
| Q1 2015 | +33,400 | Add 999.40% | 36,742 | $110.39 |
| Q4 2014 | +3,342 | New Buy | 3,342 | $104.13 |
| Q2 2014 | -4,116 | Sold Out | 0 | $0.00 |
| Q1 2014 | +4,116 | New Buy | 4,116 | $87.95 |
| Q4 2013 | -13,977 | Sold Out | 0 | $0.00 |
| Q3 2013 | +13,977 | New Buy | 13,977 | $81.71 |
Ray Dalio's The Clorox Company Investment FAQs
Ray Dalio first purchased The Clorox Company (CLX) in Q3 2013, acquiring 13,977 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held The Clorox Company (CLX) for 42 quarters since Q3 2013.
Ray Dalio's largest addition to The Clorox Company (CLX) was in Q2 2019, adding 143,723 shares worth $22 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 7,539 shares of The Clorox Company (CLX), valued at approximately $760,157.
As of the Q4 2025 filing, The Clorox Company (CLX) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in The Clorox Company (CLX) was 312,038 shares, as reported at the end of Q1 2022.